Reply: Response to RSV Prevention Strategies in Korean Children: A Review of Current Approaches and Emerging Options.
作者信息
Choe Young June
机构信息
Allergy Immunology Center, Korea University, Seoul, Korea.
Department of Pediatrics, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
出版信息
Infect Chemother. 2025 Jun;57(2):333-334. doi: 10.3947/ic.2025.0039. Epub 2025 May 2.
Abstract
摘要
相似文献
1
Reply: Response to RSV Prevention Strategies in Korean Children: A Review of Current Approaches and Emerging Options.回复：韩国儿童呼吸道合胞病毒预防策略：当前方法与新出现选择的综述
Infect Chemother. 2025 Jun;57(2):333-334. doi: 10.3947/ic.2025.0039. Epub 2025 May 2.
2
Response to RSV Prevention Strategies in Korean Children: A Review of Current Approaches and Emerging Options.韩国儿童对呼吸道合胞病毒预防策略的反应：当前方法与新出现选择的综述
Infect Chemother. 2025 Jun;57(2):331-332. doi: 10.3947/ic.2025.0024. Epub 2025 May 2.
3
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.帕利珠单抗预防高危婴儿和幼儿呼吸道合胞病毒（RSV）毛细支气管炎的免疫预防作用：亚组分析的系统评价和额外的经济建模。
Health Technol Assess. 2011 Jan;15(5):iii-iv, 1-124. doi: 10.3310/hta15050.
4
Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children: A Systematic Review and Network Meta-analysis.用于预防婴儿和儿童呼吸道合胞病毒的单克隆抗体：系统评价和网络荟萃分析。
JAMA Netw Open. 2023 Feb 1;6(2):e230023. doi: 10.1001/jamanetworkopen.2023.0023.
5
Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.使用帕利珠单抗对儿童进行呼吸道合胞病毒（RSV）免疫预防：一项系统评价与经济学评估
Health Technol Assess. 2008 Dec;12(36):iii, ix-x, 1-86. doi: 10.3310/hta12360.
6
Costs and healthcare utilisation due to respiratory syncytial virus disease in paediatric patients in Italy: a systematic review.意大利儿科患者呼吸道合胞病毒疾病的成本及医疗保健利用情况：一项系统综述
Public Health. 2024 Feb;227:103-111. doi: 10.1016/j.puhe.2023.11.039. Epub 2023 Dec 27.
7
A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis.对帕利珠单抗用于呼吸道合胞病毒免疫预防给药依从性的系统评价。
J Manag Care Pharm. 2010 Jan-Feb;16(1):46-58. doi: 10.18553/jmcp.2010.16.1.46.
8
Expert consensus on the burden of respiratory syncytial virus disease and the utility of nirsevimab for disease prevention and protection of infants.呼吸道合胞病毒疾病负担及尼塞韦单抗预防和保护婴儿疾病效用的专家共识。
World J Pediatr. 2025 Jun 28. doi: 10.1007/s12519-025-00926-2.
9
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis.全球儿童因呼吸道合胞病毒导致的急性下呼吸道感染负担：系统评价和荟萃分析。
Lancet. 2010 May 1;375(9725):1545-55. doi: 10.1016/S0140-6736(10)60206-1.
10
The burden of respiratory syncytial virus (RSV) associated acute lower respiratory infections in children with Down syndrome: A systematic review and meta-analysis.唐氏综合征患儿呼吸道合胞病毒（RSV）相关急性下呼吸道感染的负担：一项系统评价和荟萃分析。
J Glob Health. 2017 Dec;7(2):020413. doi: 10.7189/jogh.07.020413.
本文引用的文献
1
Response to RSV Prevention Strategies in Korean Children: A Review of Current Approaches and Emerging Options.韩国儿童对呼吸道合胞病毒预防策略的反应：当前方法与新出现选择的综述
Infect Chemother. 2025 Jun;57(2):331-332. doi: 10.3947/ic.2025.0024. Epub 2025 May 2.
2
RSV Prevention Strategies in Korean Children: A Review of Current Approaches and Emerging Options.韩国儿童呼吸道合胞病毒预防策略：当前方法与新出现选择的综述
Infect Chemother. 2025 Mar;57(1):31-37. doi: 10.3947/ic.2024.0122.
3
Modeling household dynamics on Respiratory Syncytial Virus (RSV).建立呼吸道合胞病毒（RSV）家庭动力学模型。
PLoS One. 2019 Jul 9;14(7):e0219323. doi: 10.1371/journal.pone.0219323. eCollection 2019.
4
Long-term Assessment of Healthcare Utilization 5 Years After Respiratory Syncytial Virus Infection in US Infants.美国婴儿呼吸道合胞病毒感染后 5 年的医疗保健利用情况的长期评估。
J Infect Dis. 2020 Mar 28;221(8):1256-1270. doi: 10.1093/infdis/jiz278.
Zotero 插件